Skip to content

R&D at other companies

Belden logo
BeldenBDC
$30.09M+5.9%
Cabot Corporation logo
Cabot CorporationCBT
$14M-6.7%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$30M+18.6%
Vontier logo
VontierVNT
$41.4M+3.0%
Archer Aviation logo
Archer AviationACHR
$171.7M+65.6%
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
$27.48M+42.2%

Segments

By segment

See full
Freight Segment$43M+19.4%
Transit Segment$13M+30.0%

Other financials

Income statement

See full
Revenue$3.0B+13.0%
Gross profit$1.1B+17.9%
Operating income$517.0M+9.1%
Net income$362.0M+12.4%
EPS (diluted)$2.12+12.8%

Balance sheet

See full
Cash & equivalents$531.0M-23.9%
Total debt$6.9B+60.5%
Total equity$11.1B+7.1%
Total assets$23.2B+21.5%

Cash flow

See full
Operating cash flow$199.0M+4.2%
CapEx$46.0M+4.5%
Free cash flow$153.0M+4.1%

Valuation

See full
Market cap$47.93B+40.0%
Enterprise value$54.31B+43.5%
P/E39.6×+8.7×
P/S4.2×+0.9×

Profitability

See full
Gross margin34.5%+1.6pp
Operating margin16%0.0pp
Net margin10.5%0.0pp
FCF margin13.1%-0.9pp

Returns & leverage

See full
Return on equity11.3%+0.7pp
Debt / equity0.6×+0.2×
Current ratio-0.3×

Where this comes from

Reported directly by Wabtec in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Wabtec’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Wabtec's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Wabtec's R&D?
Wabtec (WAB) reported R&D of $56M in Q1 2026.
How has Wabtec's R&D changed year-over-year?
Wabtec's R&D increased by 21.7% year-over-year, from $46M to $56M.
What is the long-term trend for Wabtec's R&D?
Over 4 years (2021 to 2025), Wabtec's R&D has grown at a 6.1% compound annual growth rate (CAGR), from $176M to $223M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.